ARICEPT for Alzheimer's

ARICEPT_cover.PNG
ARICEPT_cover.PNG

ARICEPT for Alzheimer's

0.00

FDA approved ARICEPT for Alzheimer's in 1996 based on evidence from four randomized trials with similar results. The longest of the trials included 473 people with mild-to-moderate Alzheimer’s Disease (average MMSE score was 19 out of 30) who were an average of 73 years old; about half were women. Researchers randomly assigned participants to take ARICEPT 5 mg, ARICEPT 10 mg, or a placebo (inactive sugar pill) for about 6 months. Get the DrugFactsBox to see what happened. 

Read about Consumer Reports' take on ARICEPT here.

Add To Cart